Identificador persistente para citar o vincular este elemento:
https://accedacris.ulpgc.es/jspui/handle/10553/146519
| Campo DC | Valor | idioma |
|---|---|---|
| dc.contributor.author | Renones, Josefina | en_US |
| dc.contributor.author | Carreras, Humberto | en_US |
| dc.contributor.author | Anton-Lopez, Alfonso | en_US |
| dc.contributor.author | Garcia-Garcia, Angel | en_US |
| dc.contributor.author | Melian, Rafael | en_US |
| dc.contributor.author | Loro Ferrer, Juan Francisco | en_US |
| dc.contributor.author | Pinero, David P. | en_US |
| dc.date.accessioned | 2025-09-08T08:10:16Z | - |
| dc.date.available | 2025-09-08T08:10:16Z | - |
| dc.date.issued | 2025 | en_US |
| dc.identifier.issn | 2222-3959 | en_US |
| dc.identifier.other | WoS | - |
| dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/146519 | - |
| dc.description.abstract | AIM: To assess whether the implantation of a posterior chamber phakic intraocular lens produces changes in optical coherence tomography (OCT) measurements of macular thickness (MT) and two parameters that define the structure of the optic nerve, the peripapillary nerve fiber layer (RNFL) and the Bruch's membrane opening-minimum rim width (BMO-MRW). circle METHODS: This nonrandomized prospective pre-post study included 86 eyes of 48 patients (age, 20-47y; axial length: 23.10-28.95 mm) scheduled for myopia or myopic astigmatism correction with implantation of the implantable collamer lens (ICL). Eyes with glaucoma or any other ocular disease that could alter OCT results were excluded. RNFL, BMO-MRW and MT were measured preoperatively, and at 1 and 6mo after surgery using spectral-domain OCT. Changes between preoperative and postoperative values were evaluated. circle RESULTS: There was a significant increase in BMO-MRW at 1mo (mean change: 3.48 +/- 15.07 mu m, P=0.041). No significant changes were found during the rest of follow up (1-6mo postop., P=0.623). There was also a significant increase in RNFL thickness at 1mo after surgery (1.45 +/- 2.18 mu m, P<0.001), but with a significant reduction from 1 to 6mo postoperatively (P=0.002). Regarding MT, it increased significantly at 1mo (2.46 +/- 3.76 <mu>m, P<0.001), with a significant decrease afterwards (P=0.048). Measurements of the three parameters at 6mo were slightly superior to preoperative values (P<0.01). circle CONCLUSION: Minimal changes are induced in BMO-MRW, RNFL and MT after ICL implantation in healthy eyes, confirming the safety of the surgical procedure regarding the structure of the optic nerve head and the macula, and indicating that this phakic intraocular lens seems to have a slight impact on OCT measurements. | en_US |
| dc.language | eng | en_US |
| dc.relation.ispartof | International Journal of Ophthalmology | en_US |
| dc.source | International Journal Of Ophthalmology [ISSN 2222-3959], v. 18 (9), p. 1658-1664, (Septiembre 2025) | en_US |
| dc.subject | 32 Ciencias médicas | en_US |
| dc.subject | 3201 Ciencias clínicas | en_US |
| dc.subject | 320109 Oftalmología | en_US |
| dc.subject.other | Cataract-Surgery | en_US |
| dc.subject.other | Collamer Lens | en_US |
| dc.subject.other | Central Hole | en_US |
| dc.subject.other | Pressure | en_US |
| dc.subject.other | Efficacy | en_US |
| dc.subject.other | Glaucoma | en_US |
| dc.subject.other | Vision | en_US |
| dc.subject.other | Safety | en_US |
| dc.subject.other | Implantable Collamer Lens | en_US |
| dc.subject.other | Phakic Intraocular Lens | en_US |
| dc.subject.other | Posterior Chamber | en_US |
| dc.subject.other | Macular Thickness | en_US |
| dc.subject.other | Macular Edema | en_US |
| dc.subject.other | Optical Coherence Tomography | en_US |
| dc.title | Implantation of a posterior chamber phakic intraocular lens on Bruch's membrane opening-minimum rim width, retinal nerve fiber layer, and macular thickness | en_US |
| dc.type | info:eu-repo/semantics/Article | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.18240/ijo.2025.09.06 | en_US |
| dc.identifier.isi | 001561943600006 | - |
| dc.identifier.eissn | 2227-4898 | - |
| dc.description.lastpage | 1664 | en_US |
| dc.identifier.issue | 9 | - |
| dc.description.firstpage | 1658 | en_US |
| dc.relation.volume | 18 | en_US |
| dc.investigacion | Ciencias de la Salud | en_US |
| dc.type2 | Artículo | en_US |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.contributor.daisngid | No ID | - |
| dc.description.numberofpages | 7 | en_US |
| dc.utils.revision | Sí | en_US |
| dc.contributor.wosstandard | WOS:Reñones, J | - |
| dc.contributor.wosstandard | WOS:Carreras, H | - |
| dc.contributor.wosstandard | WOS:Antón-López, A | - |
| dc.contributor.wosstandard | WOS:Garcia-Garcia, A | - |
| dc.contributor.wosstandard | WOS:Melián, R | - |
| dc.contributor.wosstandard | WOS:Loro-Ferrer, JF | - |
| dc.contributor.wosstandard | WOS:Piñero, DP | - |
| dc.date.coverdate | Septiembre 2025 | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| dc.description.sjr | 0,521 | |
| dc.description.jcr | 1,9 | |
| dc.description.sjrq | Q2 | |
| dc.description.jcrq | Q2 | |
| item.fulltext | Sin texto completo | - |
| item.grantfulltext | none | - |
| crisitem.author.dept | GIR IUIBS: Bioquímica | - |
| crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
| crisitem.author.dept | Departamento de Ciencias Clínicas | - |
| crisitem.author.orcid | 0000-0002-0517-8209 | - |
| crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
| crisitem.author.fullName | Loro Ferrer, Juan Francisco | - |
| Colección: | Artículos | |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.